Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance.
Lotte M G HulskotteW TöpferAnna K L ReynersKatka TaxisFrank G A JansmanPublished in: European journal of clinical pharmacology (2024)
A high frequency of pharmacologically and clinically relevant perpetrators of oxycodone was observed in our cohort. Moreover, a high number of double interactions involving oxycodone was registered. More intense monitoring of DDIs may be needed to improve medication safety of patients with cancer taking oxycodone.